Sarcoma News

Little evidence exists to support the use of most circulating tumor DNA assays in either early- or late-stage cancer, according to a newly published review by ASCO and College of American Pathologists summarizing clinical validity and utility.

People living with HIV who are diagnosed with cancer should be offered the same treatment as those without HIV; however, considerations should be made for potential interactions and toxicities, according to new practice guidelines from the National Comprehensive Cancer Network.

More than half of young adults with cancer reported ongoing problems with sexual functioning in the first 2 years following their diagnosis, according to an investigational study published in Cancer.

Local recurrence of soft tissue sarcoma is associated with distant metastases and mortality, so prompt detection is important to ensure optimal outcomes.

Larotrectinib showed activity in adults and children with TRK fusion-positive cancers, according to findings published in The New England Journal of Medicine.

A clinical trial underway at Roswell Park Comprehensive Cancer Center is designed to assess the safety and efficacy of a two-pronged strategy that arms the immune system to more effectively attack cancer cells.

The Alliance for Cancer Gene Therapy awarded $1.3 million worth of grants to fund three clinical trials that will evaluate immunotherapy and virotherapy for glioblastoma, sarcoma and ovarian cancer.

Choosing the appropriate genetic tests and managing patient expectations can be challenges clinicians face when implementing precision medicine, according to a panel discussion hosted by ASCO.

This weekend’s Super Bowl LII showdown between the New England Patriots and Philadelphia Eagles will coincide with World Cancer Day, an international observance held every Feb. 4 to emphasize the importance of cancer prevention, detection and treatment.

Nivolumab induced antitumor activity with low toxicity among a small cohort of patients with HIV-positive Kaposi sarcoma, according to preliminary study results presented at the ASCO-SITC Clinical Immuno-Oncology Symposium.